Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Primary Bone Osteosarcoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Sarcoma
Bone Sarcoma
Bone Osteosarcoma
Primary Bone Osteosarcoma

Subtype

Primary Bone Osteosarcoma

CI-CAN-00006482Explore in graph →

1 active trials4 approved drugs

NCIt: C4834

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials5
Research
Rankings
Sources & provenance

Data completeness3 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (no data yet)
Evidence (no data yet)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A usually aggressive malignant bone-forming mesenchymal neoplasm arising from the bone. It usually involves the long bones and predominantly affects adolescents and young adults. Pain and a palpable mass are the most frequent clinical sign and symptom. It may spread to other anatomic sites, particularly the lungs.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Bone OsteosarcomaSubtype

Children (8)

ncit

Bone Surface (Peripheral) Osteosarcoma3 sub
High Grade Osteosarcoma2 sub
Intermediate Grade Osteosarcoma1 sub
Low Grade Osteosarcoma2 sub
Multifocal Osteosarcoma
Osteosarcoma by AJCC v7 Stage
Small Cell Osteosarcoma
Telangiectatic Osteosarcoma

20 descendants in total; counters on this page aggregate over all of them.

Anatomy

Anatomical sites

Connective and Soft TissueC3810

Record

Identity

CancerIndex ID: CI-CAN-00006482
Entity type: Subtype
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 6
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active): 5 / 1

Publications (all / 5y)

18 / 3

Evidence items

0

Genes / variants

0 / 0

Drugs (any / approved)

0 / 4

Genomic cohorts

0

Epidemiology / survival obs.

0 / 0

Data updated 19 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (1)

Primary Osteosarcoma of Bonesynonym · NCIt

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials1countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #1186 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials0countstatus RECRUITING · entity + descendantsclinicaltrialsComputednot in a current ranking snapshot
Curated evidence items0countaccepted CIViC items · entity + descendantscivicComputednot in a current ranking snapshot
Publications, last 12 months0countPubMed records · stored query · 12-month windowpubmedComputednot in a current ranking snapshot
Genomic cohorts0countopen GDC projects · entity + descendantsgdcComputednot in a current ranking snapshot

Data updated 19 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants